Compounds > acebutolol

acebutolol and miglitol

acebutolol has been researched along with miglitol in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (28.57)	29.6817
2010's	4 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Barker, HM; Bowey, EA; Canfield, JE; Taylor, RH	1
Fujimoto, K; Furusawa, K; Jomori, T; Kimura, I; Lee, EY; Miki, T; Miyamoto, J; Taknaka, T; Uematsu, S; Zhang, X	1
Li, M; Li, XL; Liu, YX; Peng, YT; Wang, KR; Yang, JX; Zhang, HX	1

Reviews

1 review(s) available for acebutolol and miglitol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

6 other study(ies) available for acebutolol and miglitol

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Regulation of the absorption of dietary carbohydrate in man by two new glycosidase inhibitors. Gut, 1986, Volume: 27, Issue:12 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Dietary Carbohydrates; Dose-Response Relationship, Drug; Glucosamine; Glycoside Hydrolases; Humans; Hydrogen; Imino Pyranoses; Intestinal Absorption; Male; Maltose; Starch; Substrate Specificity; Sucrose	1986
Gut carbohydrate inhibits GIP secretion via a microbiota/SCFA/FFAR3 pathway. The Journal of endocrinology, 2018, 12-01, Volume: 239, Issue:3 Topics: 1-Deoxynojirimycin; Animals; Carbohydrate Metabolism; Fatty Acids, Volatile; Gastric Inhibitory Polypeptide; Gastrointestinal Microbiome; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Incretins; KATP Channels; Maltose; Mice; Receptors, G-Protein-Coupled	2018
Supramolecular azasugar clusters based on an amphiphilic fatty-acid-deoxynojirimycin derivative as multivalent glycosidase inhibitors. Journal of materials chemistry. B, 2019, 03-07, Volume: 7, Issue:9 Topics: 1-Deoxynojirimycin; alpha-Mannosidase; Animals; Blood Glucose; Cell Survival; Enzyme Inhibitors; Fatty Acids; Glucosamine; Glucose Tolerance Test; Hydrogen-Ion Concentration; Hypoglycemic Agents; Maltose; Mice	2019